These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9119131)

  • 21. A comparison of methods for the estimation of retroviral burden.
    Bierley ST; Raineri R; Poiley JA; Morgan EM
    Dev Biol Stand; 1996; 88():163-5. PubMed ID: 9119132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel, Q-PCR based approach to measuring endogenous retroviral clearance by capture protein A chromatography.
    Zhang M; Lute S; Norling L; Hong C; Safta A; O'Connor D; Bernstein LJ; Wang H; Blank G; Brorson K; Chen Q
    Biotechnol Bioeng; 2009 Apr; 102(5):1438-47. PubMed ID: 18988264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primate endogenous viruses: their role in oncogenesis and as biohazards.
    Kalter SS; Heberling RL
    Dev Biol Stand; 1976 Dec 13-15; 37():219-28. PubMed ID: 829599
    [No Abstract]   [Full Text] [Related]  

  • 24. The need for non-cultural methods for the detection of mycoplasma contaminants.
    Stanbridge EJ; Schneider EL
    Dev Biol Stand; 1976 Dec 13-15; 37():191-200. PubMed ID: 1031685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of in vitro and in vivo assays for the detection of reticuloendotheliosis virus as a contaminant in a live virus vaccine of poultry.
    Fadly AM; Witter RL
    Avian Dis; 1997; 41(3):695-701. PubMed ID: 9356718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Karyology: vaccine manufacturers' views.
    von Seefried A; Walton MJ; MacMorine HG
    Dev Biol Stand; 1976 Dec 13-15; 37():169-75. PubMed ID: 801470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing an approach to evaluate the use of neoplastic cells as vaccine substrates.
    Lewis AM
    Dev Biol (Basel); 2001; 106():37-42; discussion 42-3. PubMed ID: 11761251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mislabeling, contamination, and other sins of cultured flesh.
    Hayflick L
    Dev Biol Stand; 1976 Dec 13-15; 37():5-15. PubMed ID: 1031693
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of cell cycle status on early events in retroviral replication.
    Katz RA; Greger JG; Skalka AM
    J Cell Biochem; 2005 Apr; 94(5):880-9. PubMed ID: 15669021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the sensitivity of in vitro and in vivo tests for detection of the presence of a bovine viral diarrhoea virus type 1 strain.
    Antonis AF; Bouma A; de Bree J; de Jong MC
    Vet Microbiol; 2004 Sep; 102(3-4):131-40. PubMed ID: 15327789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M; Füssel AE
    Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal characterization of MRC-5 cell banks utilizing G-banding technique.
    Rosolowsky M; McKee R; Nichols W; Garfinkle B
    Dev Biol Stand; 1998; 93():109-17. PubMed ID: 9737385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of biological products prepared from mammalian cell culture. Detecting viruses in cell banks.
    Dev Biol Stand; 1998; 93():129. PubMed ID: 9737388
    [No Abstract]   [Full Text] [Related]  

  • 34. Examination of poliovirus vaccine preparations for SV40 sequences.
    Sangar D; Pipkin PA; Wood DJ; Minor PD
    Biologicals; 1999 Mar; 27(1):1-10. PubMed ID: 10441397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus facilitated infection of human cells with ecotropic retrovirus.
    Scott-Taylor TH; Gallardo HF; Gänsbacher B; Sadelain M
    Gene Ther; 1998 May; 5(5):621-9. PubMed ID: 9797866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Process evaluation for biopharmaceuticals: what is appropriate in process evaluation?
    Lubiniecki AS; McAllister PR; Smith TM; Shadle PJ
    Dev Biol Stand; 1996; 88():309-15. PubMed ID: 9119154
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of PCR for extranous agent testing in avian vaccines.
    Ottiger HP
    Dev Biol (Basel); 2002; 111():23-6. PubMed ID: 12678221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell bank characterization for recombinant DNA mammalian cell lines.
    Lubiniecki AS; May LH
    Dev Biol Stand; 1985; 60():141-6. PubMed ID: 4043532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
    Chen J; Reeves L; Sanburn N; Croop J; Williams DA; Cornetta K
    Virology; 2001 Mar; 282(1):186-97. PubMed ID: 11259201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A modified single-tube one-step product-enhanced reverse transcriptase (mSTOS-PERT) assay with heparin as DNA polymerase inhibitor for specific detection of RTase activity.
    Fan XY; Lü GZ; Wu LN; Chen JH; Xu WQ; Zhao CN; Guo SQ
    J Clin Virol; 2006 Dec; 37(4):305-12. PubMed ID: 16971176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.